ARCHIVES

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

How NCI’s Plans For Software Giveaway Sank In Scientific And Legal Disputes (Part Two In A Series About NCI’s Bioinformatics Venture caBIG).

March 4, 2011

New Grant Program To Fund Partnerships Between Academia, Industry, Non-Profits

March 14, 2003

NCI Continues Making Improvements In Contract Management

May 22, 1981

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

Children’s Cancer Research Institute at UT Health Science Center recruits faculty.

December 10, 2004